For patients who allow their doctors to implant medical devices in their bodies, it is a reasonable expectation that those devices have been thoroughly tested
Vivius Inc (Qnexa), Orexigen Therapeutics Inc. (Contrave), and Arena Pharmaceuticals Inc. (Lorcaserin) are the latest pharmaceutical companies moving for FDA approval of prescription weight-loss drugs.
In what could be called “too little, too late” for the impotent and corporately-influenced FDA, the orthopedic division has asked to impanel a medical-science committee
Brookdale University Hospital and Medical Center of Brooklyn, New York, finds itself defending hundreds of lawsuits for medical malpractice. New York State politicians have even made